CXCL13: A Prognostic Marker in Multiple Sclerosis
In the demyelinating autoimmune disease multiple sclerosis (MS) there is a great need for validated prognostic biomarkers that can give information about both prognosis and disease course. So far only clinical parameters have been shown to predict future outcome. CXCL13 is a potent B cell chemoattra...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Södertörns högskola, Institutionen för livsvetenskaper
2010
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:sh:diva-3656 |